Co-delivery of antigen and dual agonists by programmed mannose-targeted cationic lipid-hybrid polymersomes for enhanced vaccination

Dunwan Zhu, Chunyan Hu, Fan Fan, Yu Qin, Chenlu Huang, Zhiming Zhang, Lu Lu, Hai Wang, Hongfan Sun, Xigang Leng, Chun Wang, Deling Kong, Linhua Zhang

Research output: Contribution to journalArticlepeer-review

40 Scopus citations


Exploiting Toll-like receptor (TLR) agonists or their certain combinations can enhance the immune potency of subunit vaccine. Nevertheless, the design of co-delivery systems which can act in a synergistic and spatio-temporal way to achieve effective and durable specific immune response is still challenging. Here we fabricated mannose-functionalized lipid-hybrid polymersomes (MAN-IMO-PS) for co-delivery of ovalbumin antigen both inside the inner core and outside the lipid layer, TLR7/8 agonist imiquimod within the hydrophobic membrane, TLR4 agonist monophosphoryl lipid A in the lipid layer as programmed nanovaccine to synergistically activate immune responses for improving vaccine efficacy. After efficiently internalized by dendritic cells via mannose targeting and TLR4 ligating, MAN-IMO-PS significantly enhanced cross-presentation and cytokine production. In addition, MAN-IMO-PS showed depot effect at the injection site and enhanced migration to draining lymph nodes. Mice immunized with MAN-IMO-PS elicited greater lymphocyte activation, CD4 + and CD8 + T cell response, effector cytokines secretion, and induced Th-1 biased humoral responses. More importantly, prophylactic vaccination by MAN-IMO-PS significantly delayed tumor occurrence, suppressed tumor growth with prolonged survival, and achieved long-term immune effect. The present study demonstrates a rationally designed nanovaccine for combining antigen, different TLR agonists, and targeting moiety in a programmed manner to induce synergistic antitumor immune response.

Original languageEnglish (US)
Pages (from-to)25-40
Number of pages16
StatePublished - Jun 2019

Bibliographical note

Funding Information:
This work was financially supported by National Natural Science Foundation of China ( 81571793 , 81671806 , 51103180 , 81100100 ), CAMS Initiative for Innovative Medicine ( 2017-I2M-3-020 , 2017-I2M-4-001 ), Tianjin Municipal Natural Science Foundation ( 15JCZDJC38300 ).

Publisher Copyright:
© 2019


  • Antigen delivery
  • Cancer vaccine
  • Imiquimod
  • Lipid-hybrid polymersomes
  • Mannose-receptor targeting
  • Monophosphoryl lipid A


Dive into the research topics of 'Co-delivery of antigen and dual agonists by programmed mannose-targeted cationic lipid-hybrid polymersomes for enhanced vaccination'. Together they form a unique fingerprint.

Cite this